These findings suggest that the impact of AIP on AKI risk may be more pronounced in certain populations, highlighting the importance of monitoring AIP levels in these specific subgroups during clinical risk assessment (Fig 4; S1 Fig). This evidence concerns the gene AIP and acute kidney injury.